ArticleOncoTargets and therapy2019

Aberrantly High Expression Of NOK/STYK1 Is Tightly Associated With The Activation Of The AKT/GSK3β/N-Cadherin Pathway In Non-Small Cell Lung Cancer.

Zhao Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.